Zhongchao Inc. (NASDAQ:ZCMD – Get Free Report) saw a significant decline in short interest during the month of October. As of October 30th, there was short interest totaling 41,191 shares, a decline of 48.5% from the October 15th total of 79,926 shares. Approximately 10.0% of the company’s shares are short sold. Based on an average trading volume of 61,420 shares, the days-to-cover ratio is currently 0.7 days.
Analyst Upgrades and Downgrades
ZCMD has been the topic of several recent research reports. Wall Street Zen upgraded Zhongchao from a “strong sell” rating to a “sell” rating in a report on Saturday. Weiss Ratings cut Zhongchao from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, September 25th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company currently has an average rating of “Sell”.
Check Out Our Latest Analysis on Zhongchao
Zhongchao Stock Performance
Shares of NASDAQ ZCMD opened at $0.88 on Tuesday. Zhongchao has a fifty-two week low of $0.87 and a fifty-two week high of $1,443.36. The company’s 50 day simple moving average is $1.41 and its 200 day simple moving average is $144.49.
About Zhongchao
Zhongchao Limited is a healthcare information and education company serving China. It provides medical education and training services, including digital learning programs for healthcare professionals, as well as educational resources intended to help patients better understand health conditions and care. The company also supports healthcare communications and information initiatives for organizations in the medical and pharmaceutical sectors. Its services are designed to connect healthcare professionals and patients with relevant medical knowledge through online and other educational channels.
See Also
- Five stocks we like better than Zhongchao
- 3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake
- Tyson Foods’ 10% Surge Puts a Breakout in Sight, But Wall Street Remains Cautious
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
Receive News & Ratings for Zhongchao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhongchao and related companies with MarketBeat.com's FREE daily email newsletter.
